The Joint Clinical Research Centre (JCRC), working with Makerere University, Mbarara University of Science and Technology (MUST) and the University of Massachusetts Chan Medical School, is offering funded PhD training in cell and gene therapy for HIV cure. The programme is supported by the Fogarty International Center of the US National Institutes of Health and aims to build a new generation of African scientists in this field. It suits Ugandan biomedical and laboratory scientists, immunologists, molecular biologists and doctors with a recent master’s who want a research career in HIV cure. It is open to Ugandan nationals only. Applications close on Wednesday 2 Dec 2026.
At a glance
- Offered by: Joint Clinical Research Centre (JCRC), with Makerere University, MUST and UMass Chan Medical School; funded by the NIH Fogarty International Center
- Award: full tuition and university fees, a monthly stipend, research and fieldwork costs, training placements in the US and conference support
- Study: a full-time, four-year PhD at Makerere University or MUST
- Who can apply: Ugandans with a relevant master’s obtained within the last five years
- Deadline: Wednesday 2 Dec 2026, 11:59 PM EAT
What it offers
Fellows enrol for a doctorate at Makerere or MUST with their fees, a monthly stipend and research costs, including fieldwork, paid. They are mentored by scientists in Uganda and abroad, spend short periods of specialised training at a US partner institution, and receive training in scientific writing, grant writing and the responsible conduct of research, with support to present their findings at conferences. Research falls in one of four areas, or a related one: gene editing (for example CRISPR-Cas systems) for an HIV cure; HIV latency reversal and immune modulation; chimeric antigen receptor (CAR) T-cell therapies; and clinical-trial readiness and implementation science for cell and gene therapy.
Who can apply
- Ugandan nationals.
- A master’s degree from a recognised university, obtained within the last five years, in molecular biology, immunology, biomedical sciences, medicine, laboratory sciences or a related field.
- A strong interest in cell and gene therapy for HIV cure, and the capacity for the academic and research demands of a PhD.
- Willing to enrol in and complete a full-time, four-year PhD at Makerere or MUST, and to take short training attachments at a partner institution in the United States.
- Willing to take part in multidisciplinary research, grant applications and international collaborations.
- Admission to a PhD programme at Makerere or MUST is an advantage but is not required when you apply.
How to apply
Email your application as a single PDF to training@jcrc.org.ug with the subject line “PhD Scholarship Application 2026”. Include a cover letter (one page at most), a CV (five pages at most), a personal statement addressing the eligibility criteria (one page), a research synopsis on HIV cell and gene therapy (five pages at most), and your academic transcripts and other relevant documents. Two reference letters, at least one from an academic referee, must be sent by the referees themselves to the same address by the deadline. Apply by Wednesday 2 Dec 2026, 11:59 PM EAT. Interviews for shortlisted applicants are on 15 Dec 2026, and successful applicants will be told by 4 Jan 2027. Only shortlisted candidates will be contacted; questions go to the same email address.
JCRC is an equal opportunity institution and encourages qualified applicants from diverse backgrounds.
Source: JCRC’s call for applications (PDF), also printed in the Daily Monitor. JCRC is a Ugandan clinical research and healthcare institution, based in Lubowa, Kampala, known for its work on HIV treatment and research. CEGER shares this call for its network and is not involved in selection.
